 Elizabeth Kozora
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 14 | 2022 | 237 | 3.150 |
Why?
| | Cognition Disorders | 15 | 2022 | 538 | 2.600 |
Why?
| | Neuropsychological Tests | 21 | 2022 | 1134 | 1.310 |
Why?
| | Cognition | 11 | 2022 | 1262 | 1.060 |
Why?
| | Leukoencephalopathies | 2 | 2013 | 24 | 0.720 |
Why?
| | Antiphospholipid Syndrome | 4 | 2016 | 32 | 0.710 |
Why?
| | Coronary Artery Bypass | 5 | 2019 | 265 | 0.670 |
Why?
| | Depression | 6 | 2011 | 1557 | 0.650 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 6 | 2021 | 919 | 0.570 |
Why?
| | Antibodies, Antiphospholipid | 3 | 2016 | 24 | 0.540 |
Why?
| | Emphysema | 3 | 2011 | 100 | 0.530 |
Why?
| | Pulmonary Emphysema | 2 | 2011 | 275 | 0.510 |
Why?
| | Coronary Artery Bypass, Off-Pump | 6 | 2017 | 16 | 0.470 |
Why?
| | Memory Disorders | 4 | 2017 | 194 | 0.450 |
Why?
| | Lupus Vasculitis, Central Nervous System | 3 | 2018 | 14 | 0.420 |
Why?
| | Cognitive Dysfunction | 4 | 2021 | 464 | 0.390 |
Why?
| | Pneumonectomy | 2 | 2011 | 167 | 0.370 |
Why?
| | Trail Making Test | 1 | 2011 | 5 | 0.360 |
Why?
| | Attention | 4 | 2019 | 458 | 0.290 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 228 | 0.270 |
Why?
| | Memory | 5 | 2010 | 296 | 0.270 |
Why?
| | Antibodies | 1 | 2010 | 396 | 0.270 |
Why?
| | Smoking | 3 | 2020 | 1466 | 0.270 |
Why?
| | Executive Function | 4 | 2022 | 460 | 0.250 |
Why?
| | Nervous System Diseases | 1 | 2008 | 283 | 0.230 |
Why?
| | Fatigue | 2 | 2011 | 363 | 0.220 |
Why?
| | Middle Aged | 21 | 2020 | 35892 | 0.200 |
Why?
| | Quality of Life | 4 | 2021 | 3180 | 0.200 |
Why?
| | Anxiety | 2 | 2011 | 1114 | 0.200 |
Why?
| | Humans | 38 | 2022 | 144298 | 0.190 |
Why?
| | Behavior | 1 | 2002 | 90 | 0.180 |
Why?
| | Carotid Arteries | 2 | 2021 | 207 | 0.180 |
Why?
| | Pain | 1 | 2006 | 781 | 0.160 |
Why?
| | Memory, Short-Term | 2 | 2013 | 271 | 0.160 |
Why?
| | Graft Occlusion, Vascular | 2 | 2019 | 40 | 0.160 |
Why?
| | Female | 24 | 2020 | 78137 | 0.160 |
Why?
| | Choline | 3 | 2013 | 136 | 0.160 |
Why?
| | Male | 24 | 2020 | 72263 | 0.160 |
Why?
| | Psychometrics | 2 | 2017 | 731 | 0.160 |
Why?
| | Verbal Behavior | 2 | 2013 | 43 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2020 | 69 | 0.150 |
Why?
| | Brain | 5 | 2018 | 2929 | 0.150 |
Why?
| | Smokers | 1 | 2019 | 137 | 0.140 |
Why?
| | Angina Pectoris | 1 | 2019 | 75 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2013 | 623 | 0.140 |
Why?
| | Frontal Lobe | 2 | 2013 | 159 | 0.140 |
Why?
| | Psychomotor Performance | 3 | 2011 | 328 | 0.130 |
Why?
| | Treatment Outcome | 9 | 2019 | 11713 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 5 | 2018 | 3879 | 0.130 |
Why?
| | Coronary Angiography | 1 | 2019 | 324 | 0.130 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2021 | 300 | 0.120 |
Why?
| | Autoantibodies | 3 | 2018 | 1504 | 0.120 |
Why?
| | Learning | 2 | 2013 | 448 | 0.110 |
Why?
| | Single-Blind Method | 3 | 2011 | 318 | 0.110 |
Why?
| | Physical Endurance | 2 | 2010 | 274 | 0.110 |
Why?
| | Central Nervous System Diseases | 1 | 2016 | 74 | 0.110 |
Why?
| | Adult | 11 | 2013 | 40408 | 0.110 |
Why?
| | Vascular Stiffness | 1 | 2020 | 485 | 0.110 |
Why?
| | Case-Control Studies | 4 | 2012 | 3595 | 0.110 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 496 | 0.110 |
Why?
| | Coronary Artery Disease | 2 | 2014 | 743 | 0.100 |
Why?
| | Rheumatology | 2 | 2006 | 133 | 0.100 |
Why?
| | Coronary Circulation | 1 | 2014 | 133 | 0.100 |
Why?
| | Health Status Indicators | 2 | 2011 | 166 | 0.090 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 97 | 0.090 |
Why?
| | Motor Skills | 1 | 2013 | 104 | 0.090 |
Why?
| | Aged | 10 | 2020 | 25901 | 0.090 |
Why?
| | Neurologic Examination | 2 | 2008 | 131 | 0.090 |
Why?
| | Linear Models | 2 | 2011 | 845 | 0.080 |
Why?
| | Creatinine | 1 | 2013 | 509 | 0.080 |
Why?
| | Prospective Studies | 3 | 2019 | 7972 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5404 | 0.080 |
Why?
| | Regression Analysis | 1 | 2013 | 997 | 0.080 |
Why?
| | Immunologic Factors | 1 | 2013 | 258 | 0.080 |
Why?
| | Forced Expiratory Volume | 1 | 2011 | 448 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2917 | 0.080 |
Why?
| | Acetylcholine | 1 | 2010 | 208 | 0.070 |
Why?
| | Cardiopulmonary Bypass | 1 | 2011 | 216 | 0.070 |
Why?
| | Aspartic Acid | 2 | 2009 | 87 | 0.070 |
Why?
| | Postoperative Complications | 3 | 2014 | 2939 | 0.070 |
Why?
| | Brain Chemistry | 2 | 2009 | 116 | 0.070 |
Why?
| | Neuroimaging | 1 | 2011 | 293 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2006 | 3408 | 0.060 |
Why?
| | Muscle Strength | 1 | 2010 | 330 | 0.060 |
Why?
| | West Nile Fever | 1 | 2008 | 57 | 0.060 |
Why?
| | Coronary Disease | 1 | 2009 | 381 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 392 | 0.060 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2008 | 180 | 0.060 |
Why?
| | Multiple Sclerosis | 2 | 2016 | 483 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 713 | 0.060 |
Why?
| | Mental Processes | 1 | 2005 | 38 | 0.060 |
Why?
| | Prednisone | 1 | 2006 | 221 | 0.060 |
Why?
| | Ohio | 1 | 2005 | 143 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1075 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 793 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1388 | 0.050 |
Why?
| | Respiratory Function Tests | 2 | 2019 | 541 | 0.050 |
Why?
| | Pain Measurement | 1 | 2006 | 553 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2940 | 0.050 |
Why?
| | Lung | 2 | 2019 | 4084 | 0.050 |
Why?
| | Vascular Patency | 2 | 2014 | 121 | 0.050 |
Why?
| | Language | 1 | 2005 | 322 | 0.040 |
Why?
| | Biomarkers | 1 | 2013 | 4248 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 966 | 0.040 |
Why?
| | Carotid Artery, Common | 1 | 2021 | 31 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 2 | 2019 | 771 | 0.040 |
Why?
| | Reaction Time | 2 | 2017 | 438 | 0.040 |
Why?
| | United States | 4 | 2019 | 15979 | 0.040 |
Why?
| | Risk Factors | 3 | 2020 | 10783 | 0.040 |
Why?
| | Societies, Medical | 1 | 2004 | 890 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3680 | 0.040 |
Why?
| | Hippocampus | 1 | 2005 | 964 | 0.040 |
Why?
| | Time Factors | 3 | 2019 | 7128 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 2081 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2021 | 441 | 0.030 |
Why?
| | Blood-Brain Barrier | 1 | 2018 | 155 | 0.030 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 6035 | 0.030 |
Why?
| | Self-Assessment | 1 | 2017 | 74 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 342 | 0.030 |
Why?
| | Culture | 1 | 2017 | 125 | 0.030 |
Why?
| | Pilot Projects | 2 | 2013 | 1880 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1537 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 768 | 0.030 |
Why?
| | Movement Disorders | 1 | 2016 | 70 | 0.030 |
Why?
| | Colorado | 1 | 2005 | 4554 | 0.030 |
Why?
| | Brain Ischemia | 1 | 2018 | 358 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2113 | 0.020 |
Why?
| | Young Adult | 1 | 2010 | 14092 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1739 | 0.020 |
Why?
| | Coronary Vessels | 1 | 2014 | 246 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3324 | 0.020 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 103 | 0.020 |
Why?
| | Rituximab | 1 | 2013 | 211 | 0.020 |
Why?
| | Spiritualism | 1 | 2011 | 1 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 2043 | 0.020 |
Why?
| | Religion | 1 | 2011 | 65 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 22370 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 513 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5862 | 0.020 |
Why?
| | Creatine | 1 | 2009 | 63 | 0.020 |
Why?
| | Health Resources | 1 | 2009 | 130 | 0.020 |
Why?
| | Mental Status Schedule | 1 | 2008 | 35 | 0.020 |
Why?
| | Axons | 1 | 2009 | 202 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2886 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2862 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2011 | 308 | 0.020 |
Why?
| | Technology Assessment, Biomedical | 1 | 2007 | 44 | 0.020 |
Why?
| | Mental Disorders | 1 | 2016 | 1153 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 675 | 0.020 |
Why?
| | Sample Size | 1 | 2007 | 120 | 0.020 |
Why?
| | Walking | 1 | 2011 | 542 | 0.010 |
Why?
| | Verbal Learning | 1 | 2005 | 73 | 0.010 |
Why?
| | Prevalence | 1 | 2012 | 2836 | 0.010 |
Why?
| | Veterans | 1 | 2017 | 1614 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2170 | 0.010 |
Why?
| | Health Surveys | 1 | 2007 | 516 | 0.010 |
Why?
| | Safety | 1 | 2007 | 354 | 0.010 |
Why?
| | Research Design | 1 | 2007 | 1128 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 17104 | 0.010 |
Why?
|
|
Kozora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|